SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst a turbulent period, primarily driven by the contentious Warner Bros. Discovery acquisition saga and a competing bid from Paramount Skydance. Community sentiment is notably divided, with many investors expressing concern over the deal's potential debt implications and regulatory scrutiny, while others view the stock's significant downturn as an oversold opportunity ahead of its anticipated Q4 earnings report.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending due to reports of a Department of Justice probe into Fed Chair Jerome Powell, which many perceive as political pressure to influence interest rates and undermine the Federal Reserve's independence. The community is sharply divided, with some fearing significant market instability and a loss of investor confidence, while others express support for the action against Powell, leading to widespread anticipation of heightened volatility and potential market declines.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is experiencing significant volatility as a new manufacturing partnership to boost production and margins clashes with concerns over a recently announced private placement and warrants priced at a lower exercise value. The community is hotly debating whether the stock's low float will ignite a sustained short squeeze reminiscent of other recent runners or if imminent dilution will lead to a substantial price correction.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is experiencing significant volatility amid intensified competition, as Amazon Pharmacy now offers a popular weight loss pill, alongside a recent downgrade by Bank of America citing lofty 2026 estimates. This combination has ignited a fierce debate among investors, with many bears predicting further declines and questioning the company's competitive moat, while bulls highlight institutional holding, international expansion, and the potential for a short squeeze based on Hims' long-term vision in personalized healthcare.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending after impressive CES demonstrations showcased its advanced agentic and voice AI solutions, including new partnerships with TomTom for automotive navigation and Richtech Robotics. Enthusiastic bulls anticipate a major rally and short squeeze, citing the company's innovative technology and growing client base as key differentiators against broader market skepticism and perceived price suppression. The conversation centers on SoundHound's potential as a specialized leader in the rapidly expanding conversational AI market, offering unique privacy-focused enterprise solutions.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF is trending as a criminal probe into Federal Reserve Chair Jerome Powell by the Department of Justice fuels intense community debate about the central bank's independence and future monetary policy. Investors are closely monitoring the market's reaction, anticipating heightened volatility and reevaluating broader economic stability in light of these significant political developments affecting key sectors like financials.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

Invesco QQQ Trust is trending amid significant market uncertainty following reports of a criminal investigation into Federal Reserve Chair Jerome Powell by the Department of Justice. The community is actively debating the implications of this unprecedented political pressure on Fed independence, with many bracing for increased volatility in technology and growth stocks. While some view it as a fleeting political maneuver, others express deep concern about its potential impact on monetary policy and market stability.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings (ANPA) is trending following its acquisition of TikTok icon Khaby Lame's core company and a significant private placement. This has ignited highly speculative interest and intense volatility, with many in the community anticipating a substantial short squeeze reminiscent of other recent low-float Hong Kong-based surges. Conversely, significant skepticism remains around the company's valuation and the long-term sustainability of the price action.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is surging on widespread speculation surrounding a potential acquisition by Eli Lilly, with reports from French media and government indicating broader big pharma interest in its promising ulcerative colitis treatment, obefazimod. The community is actively debating potential buyout valuations and the underlying strength of its Phase 3 data, fueling significant options activity amidst an active biotech M&A landscape.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as investors grapple with conflicting signals from political pressure for Federal Reserve rate cuts and recent mixed economic data. Community discussion is sharply divided, with some anticipating significant gains for TLT on expected monetary easing and safe-haven demand, while others foresee continued bearish pressure due to persistent inflation, substantial government debt, and geopolitical uncertainties.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Phreesia, Inc. (NYSE:PHR) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) have received a consensus rating of "Moderate Buy" from the eighteen research firms that are covering the stock, Marketbeat Ratings reports. One...

Phreesia, Inc. (NYSE:PHR) Short Interest Down 30.2% in December

Phreesia, Inc. (NYSE:PHR - Get Free Report) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 2,427,866 shares, a decline of...

Capricorn Fund Managers Ltd Takes Position in Phreesia, Inc. $PHR

Capricorn Fund Managers Ltd acquired a new position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The...

Phreesia (NYSE:PHR) Sees Strong Trading Volume - Here's Why

Phreesia (NYSE:PHR) Sees Strong Trading Volume - Should You Buy...

Mizuho Lowers Phreesia (NYSE:PHR) Price Target to $28.00

Mizuho lowered their price target on Phreesia from $36.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday...

Phreesia (PHR) Loses 32.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Phreesia (PHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Why Phreesia Stock Plummeted by 23% Today

Key PointsInvestors enthusiastically traded out of the stock, despite its good performance across all three business lines...

Citigroup Issues Pessimistic Forecast for Phreesia (NYSE:PHR) Stock Price

Citigroup reduced their price objective on Phreesia from $34.00 to $29.00 and set a "buy" rating on the stock in a report on Tuesday...

JPMorgan Chase & Co. Cuts Phreesia (NYSE:PHR) Price Target to $29.00

JPMorgan Chase & Co. dropped their price target on shares of Phreesia from $32.00 to $29.00 and set an "overweight" rating on the stock in a research report on Tuesday...

Phreesia (NYSE:PHR) Reaches New 52-Week Low - Here's Why

Phreesia (NYSE:PHR) Hits New 12-Month Low - What's Next...

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Phreesia Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

PHR
Phreesia Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PHR News

PHRPhreesia Inc